Diabetic Nephropathy
| dc.contributor.editor | Chan, John S. D. | |
| dc.date.accessioned | 2021-04-20T15:31:42Z | |
| dc.date.available | 2021-04-20T15:31:42Z | |
| dc.date.issued | 2012 | |
| dc.identifier | ONIX_20210420_9789535105435_1376 | |
| dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/66018 | |
| dc.description.abstract | Internationally renowned experts have provided data on their own studies, and discuss the relative usefulness of their work in relation to diabetic nephropathy. The first section describes the novel role of intrarenal renin-angiotensin-aldosterone system (RAAS) and oxidative stress in the development of diabetic nephropathy and discusses the current and novel pharmacological interventions in the treatment of diabetic nephropathy. The second section discusses other important contributors outside of the RAAS in the pathogenesis of diabetic nephropathy including AGE/RAGE, epithelial-mesenchymal-transition (EMT) and immune cytokines. Features: Provides novel information on various pathophysiological determinants in the development of diabetic nephropathy Provides novel information on various pharmacological interventions of diabetic nephropathy | |
| dc.language | English | |
| dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJQ Ophthalmology | en_US |
| dc.subject.other | Renal medicine & nephrology | |
| dc.title | Diabetic Nephropathy | |
| dc.type | book | |
| oapen.identifier.doi | 10.5772/1889 | |
| oapen.relation.isPublishedBy | 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 | |
| oapen.relation.isbn | 9789535105435 | |
| oapen.relation.isbn | 9789535169789 | |
| oapen.imprint | IntechOpen | |
| oapen.pages | 178 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/3.0/